This may reflect the role of DNGR-1 as a surrogate marker for cDC1 abundance in the tumor microenvironment, or it might indicate a more prominent role for DNGR-1 in cancer immunity in humans compared to mice bearing transplantable cancers. The gene discussed is CLEC9A; the disease is cancer.